Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Heliyon|December 8, 2021
Articulating the exuberant intricacies of bacterial exopolysaccharides to purge environmental pollutantsKrina Mehta, Arpit Shukla, Meenu Saraf
Molecular Biotechnology|September 25, 2021
An Anecdote on Prospective Protein Targets for Developing Novel Plant Growth RegulatorsRohit Patel, Krina Mehta, Dweipayan Goswami, et al.
Clinical Pharmacokinetics|February 21, 2023
Predictions of Bedaquiline and Pretomanid Target Attainment in Lung Lesions of Tuberculosis Patients using Translational Minimal Physiologically Based Pharmacokinetic ModelingKrina Mehta, Tingjie Guo, Piet H van der Graaf, et al.
British Journal of Clinical Pharmacology|October 11, 2023
Model-based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug-resistant tuberculosisKrina Mehta, Tingjie Guo, Piet H van der Graaf, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 16, 2025
The dawn of a new era: can machine learning and large language models reshape QSP modeling?Ioannis P Androulakis, Lourdes Cucurull-Sanchez, Anna Kondic, et al.
Clinical Pharmacokinetics|March 26, 2024
Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic ModelingKrina Mehta, Pavel Balazki, Piet H van der Graaf, et al.
Clinical Pharmacology and Therapeutics|August 12, 2024
Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient-Reported Outcomes in Adults With X-Linked HypophosphatemiaKrina Mehta, Nathalie H Gosselin, Karl Insogna, et al.
Journal of Clinical Pharmacology|September 30, 2024
Pharmacodynamic Exposure-Response Analysis of Fracture Count Data Following Treatment with Burosumab in Patients with XLHKrina Mehta, Jose Storopoli, Nikita Ramwani, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Quantitative Systems Pharmacology Modeling Framework of Autophagy in Tuberculosis: Application to Adjunctive Metformin Host-Directed TherapyKrina Mehta, Tingjie Guo, Robert S Wallis, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
Pageof 2